Friday, August 23, 2024
Low Hemoglobin Levels Linked to Retinopathy in Preterm Infants
Indian study finds increased risk for premature babies with low hemoglobin levels.
Friday, August 23, 2024
Indian study finds increased risk for premature babies with low hemoglobin levels.
Tuesday, August 20, 2024
Campaign highlights the importance of retina specialists in combating retinal diseases.
Tuesday, August 20, 2024
OPGx-LCA5 is currently being studied in clinical trial as a treatment for Leber congenital amaurosis.
Tuesday, August 20, 2024
The company's ATSN-201 may provide hope for patients with X-linked retinoschisis.
Tuesday, August 20, 2024
Study reveals a significant decline in postoperative eye infection rates, likely due to improved treatment practices.
Tuesday, August 20, 2024
New study demonstrates potential for intravitreal retinal progenitor cell therapy in mitigating photoreceptor degeneration.
Tuesday, August 13, 2024
Monday, August 12, 2024
First patients dosed in clinical trial for novel corticosteroid implant.
Monday, August 12, 2024
Epiretinal macrophage–like cells could help monitor progression of diabetic retinopathy.
Monday, August 12, 2024
The new device, approved by the FDA earlier this year, delivers Acthar Gel, a uveitis treatment.
Monday, August 12, 2024
The SOL-R trial will evaluate the company's Axitinib implant as a treatment for wet age-related macular degeneration.
Monday, August 12, 2024
Eyedaptic's new Eye6 smart glasses utilize an AI assistant to help patients with daily tasks.
Monday, August 12, 2024
The new code, which will go into effect next year, will facilitate reimbursement for PBM treatment in patients with dry AMD.
Monday, August 12, 2024
Patients treated with Eylea HD showed significant gains in visual acuity, regardless of their baseline BCVA.
Tuesday, July 30, 2024
Post hoc analysis reveals slightly increased MNV incidence with avacincaptad pegol 2 mg, but similar efficacy in geographic atrophy growth reduction regardless of MNV development.
Monday, July 29, 2024
Study reveals enzyme’s role in lysosome dysfunction and drusen formation in age-related macular degeneration.
Monday, July 29, 2024
The Spectralis OCTA module with SHIFT technology reduces acquisition time by 50% while maintaining high image quality.